What is Hamilton Robotics EMEA's cybersecurity risk score?

Hamilton Robotics EMEA has an AI-generated cybersecurity risk score of 748 out of 1000, indicating a Moderate security posture according to Rankiteo's assessment.

How many security incidents has Hamilton Robotics EMEA experienced?

According to Rankiteo, Hamilton Robotics EMEA currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has Hamilton Robotics EMEA been affected by any supply chain cyber incidents ?

According to Rankiteo, Hamilton Robotics EMEA has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does Hamilton Robotics EMEA have SOC 2 Type 1 certification ?

According to Rankiteo, Hamilton Robotics EMEA is not certified under SOC 2 Type 1.

Does Hamilton Robotics EMEA have SOC 2 Type 2 certification ?

According to Rankiteo, Hamilton Robotics EMEA does not hold a SOC 2 Type 2 certification.

Does Hamilton Robotics EMEA comply with GDPR ?

According to Rankiteo, Hamilton Robotics EMEA is not listed as GDPR compliant.

Does Hamilton Robotics EMEA have PCI DSS certification ?

According to Rankiteo, Hamilton Robotics EMEA does not currently maintain PCI DSS compliance.

Does Hamilton Robotics EMEA comply with HIPAA ?

According to Rankiteo, Hamilton Robotics EMEA is not compliant with HIPAA regulations.

Does Hamilton Robotics EMEA have ISO 27001 certification ?

According to Rankiteo,Hamilton Robotics EMEA is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does Hamilton Robotics EMEA operate in ?

Hamilton Robotics EMEA operates primarily in the Biotechnology Research industry.

How many employees does Hamilton Robotics EMEA have ?

Hamilton Robotics EMEA employs approximately 7 people worldwide.

Does Hamilton Robotics EMEA own any subsidiaries ?

Hamilton Robotics EMEA presently has no subsidiaries across any sectors.

How many LinkedIn followers does Hamilton Robotics EMEA have ?

Hamilton Robotics EMEA's official LinkedIn profile has approximately 5,378 followers.

What is the NAICS classification code for Hamilton Robotics EMEA ?

Hamilton Robotics EMEA is classified under the NAICS code 541714, which corresponds to Research and Development in Biotechnology (except Nanobiotechnology).

Does Hamilton Robotics EMEA have a Crunchbase profile ?

No, Hamilton Robotics EMEA does not have a profile on Crunchbase.

Does Hamilton Robotics EMEA have a LinkedIn profile ?

Yes, Hamilton Robotics EMEA maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/hamilton-robotics-emea.

How many cybersecurity incidents has Hamilton Robotics EMEA experienced ?

As of July 10, 2026, Rankiteo reports that Hamilton Robotics EMEA has not experienced any cybersecurity incidents.

How many peer or competitor companies does Hamilton Robotics EMEA have ?

Hamilton Robotics EMEA has an estimated 4,719 peer or competitor companies worldwide.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

HRE

Boost Score +25 with badge (5 left)

748

/1000

Moderate

773

/1000

Fair

Hamilton Robotics EMEA Vendor Cyber Rating & Cyber Score

hamiltoncompany.com

Add Your Compliance Badge

Hamilton Robotics EMEA delivers precision automated liquid handling systems that accelerate scientific discovery and improve laboratory workflows worldwide. We design, manufacture, and support a comprehensive portfolio of automated liquid handling solutions, from compact benchtop systems to fully integrated high-throughput workstations. Our offerings include modular liquid handling platforms, application-specific Assay Ready Workstations, precision consumables, and custom OEM integration solutions. Whether automating pipetting, sample preparation, or complex multi-step workflows, our systems deliver unmatched accuracy, reliability, and scalability that grow with your lab.

HRE A.I CyberSecurity Scoring

Scoring History

HRE

Hamilton Robotics EMEA CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

No data available

Loading…

A.I.

HRE Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for HRE

Incidents vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Hamilton Robotics EMEA in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for Hamilton Robotics EMEA in 2026.

Incident Types HRE vs Biotechnology Research Industry Avg (This Year)

No incidents recorded for Hamilton Robotics EMEA in 2026.

Incident History - HRE (X = Date, Y = Severity)

Loading…

SUBSIDIARY

Hamilton Robotics EMEA Subsidiaries

Parent Company

HRE

Biotechnology Research

Website: http://www.hamiltoncompany.com/products/automated-liquid-handling/liquid-handling-workstations

Company Size: 501-1,000 employees

No subsidiary data available for this company.

Loading…

Hamilton Robotics EMEA Similar Companies

Thermo Fisher Scientific

thermofisher.com

About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

Genentech

gene.com

About Genentech We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours. If you’d like to join our team, view our openings at gene.com/careers. Our patient resource center is dedicated to getting patients and caregivers to the right resources. You can reach them at 1 (877) GENENTECH (436-3683) Monday-Friday, 6am-5pm PST or [email protected]. Community Guidelines: 1. We want to foster positive conversation around the issues we are passionate about. To that end, we remove profanity, content that contains threatening language, content that is aimed at private individuals, personal information, and repeated unwanted messages. 2. Don’t mention any medicines by name — ours or anyone else’s. Because of the fair balance rules governing our industry, we cannot post any comments that reference any pharmaceutical brand, product, or service. Please do not mention any specific medicines by name, or include any links to third party sites in your comments. 3. This isn’t the place to report or discuss side effects. This site is not intended as a forum for reporting side effects experienced while taking a Genentech product. Instead, you should report any side effects to Genentech Drug Safety at 1-888-835-2555. You can also report side effects of any prescription product directly to the FDA at 1-800-FDA-1088 or by visiting www.FDA.gov/medwatch. 4. Don’t pitch your product or service. Please don't use our page as a place to promote your product or pitch your services. Please also avoid posting links to external sites. We reserve the right to remove any posts that are deemed promotional.

Eurofins

cb eurofins.com

Since 1987, Eurofins has grown from one laboratory in Nantes, France to over 65,000 staff across a network of independent companies in 60 countries, operating over 950 laboratories. Performing over 450 million tests every year, Eurofins offers a portfolio of over 200,000 analytical methods to evaluate the safety, identity, composition, authenticity, origin, traceability and purity of biological substances and products, as well as providing innovative clinical diagnostic testing services, as one of the leading global emerging players in specialised clinical diagnostics testing. Ever since its IPO on the French stock exchange in 1997, Eurofins has been one of the fastest growing listed European companies.

Avantor

cb avantorsciences.com

Avantor® is a leading global provider of mission-critical products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. Our portfolio is used in virtually every stage of the most important research, development and production activities in the industries we serve. Our global footprint enables us to serve more than 300,000 customer locations and gives us extensive access to research laboratories and scientists in more than 180 countries. We set science in motion to create a better world. More than 14,500 strong, our associates are passionate about our mission to set science in motion to create a better world. We share enthusiasm for innovation, excellence, and achievement. Whether we are collaborating with our customers to advance science or solve multifaceted problems, we help them reach their goals more efficiently and effectively. Visit our website to learn more about Avantor.

ICON plc

iconplc.com

Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life. We do this by delivering best in class information, solutions and performance, with an unyielding focus on quality at all times. We offer a full range of consulting, development and commercialisation services from a global network of offices in 53 countries. We focus our innovation on the factors that are critical to our clients – reducing time to market, reducing cost, and increasing quality – and our global team of experts has extensive experience in a broad range of therapeutic areas.

bioMérieux

biomerieux.com

A family-owned company, bioMérieux has grown to become a world leader in the field of in vitro diagnostics. Our entrepreneurial adventure, begun over a century ago, is driven by an unrelenting commitment to improve public health worldwide. Since 1963, we've been paving the way in the field of in vitro diagnostics and have contributed greatly to improving public health and making the world a healthier place. The solutions that our teams imagine, develop and manufacture are key to enable healthcare professionals and industry players to make confident decisions to improve patient outcome and ensure consumer safety.

Fortrea

fortrea.com

Fortrea (Nasdaq: FTRE) is a leading global clinical research organization (CRO) dedicated to providing innovative clinical development solutions to the life sciences industry. With over 30 years of clinical research experience, Fortrea has evolved from Covance and Labcorp into a pureplay CRO built for biotech, biopharma, medical device and diagnostic innovators. Fortrea collaborates with both emerging and established companies to deliver agile, fit-for-purpose full service (FSO), functional service (FSP) and hybrid solutions. Fortrea provides comprehensive Phase I-IV clinical trial management, clinical pharmacology, and consulting services, backed by deep experience in more than 20 therapeutic areas. Operating in approximately 100 countries, our diverse and talented team brings scientific rigor, operational excellence, and a strong investigator site network to every trial. By combining the best of our legacy experience with forward-thinking innovation, Fortrea brings predictability to clinical trial execution and helps transform aspirations into outcomes. Together, exceptional is possible. Learn more at Fortrea.com

CSL

cb csl.com

CSL is a leading global biopharma company with a dynamic portfolio of lifesaving medicines, including those that treat haemophilia and immune deficiencies, vaccines to prevent influenza, and therapies in iron deficiency, dialysis and nephrology. Since our start in 1916, we have been driven by our promise to save lives using the latest technologies. Today, CSL – including our businesses, CSL Behring, CSL Seqirus, and CSL Vifor – provides lifesaving products to patients in more than 100 countries and employs 29,000+ people. Our unique combination of commercial strength, R&D focus and operational excellence enables us to identify, develop and deliver innovations so our patients can live life to the fullest. See our community guidelines: https://bit.ly/3Bs17Ra

Roche

cb roche.com

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation

Loading…

NEWS

Hamilton Robotics EMEA CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-59858

SUMMARY

Vim is an open source, command line text editor. Prior to 9.2.0735, the C omni-completion script in runtime/autoload/ccomplete.vim interpolates the typeref: or typename: extension field of a tags entry, without escaping, into a :vimgrep pattern that is run through :execute. Because :vimgrep honors the bar as a command separator, a crafted tag field can close the search pattern and append an arbitrary Ex command; opening a hostile .c file whose project tags file contains such an entry and invoking C omni-completion runs that command as the editing user. This issue is fixed in version 9.2.0735.

Published

Date2026-07-09

Updated

Date2026-07-09

RISK INFORMATION (Score: )

cvss4

Base Score: 8.4

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-59857

SUMMARY

Vim is an open source, command line text editor. Prior to 9.2.0725, the single-byte branch of spell_soundfold_sal() in src/spell.c translates a word through a spell file's SAL sound-folding rules into a caller-owned result buffer, but its result writes are guarded with reslen < MAXWLEN, allowing reslen to reach MAXWLEN before res[reslen] = NUL writes one byte past the end of the MAXWLEN-element stack buffer. A boundary-length word passed to soundfold(), or reached via sound-based spell suggestion while a SAL-based spell language is active under a non-multibyte 8-bit encoding, can corrupt the eval_soundfold() stack frame and crash the editor. This issue is fixed in version 9.2.0725.

Published

Date2026-07-09

Updated

Date2026-07-09

RISK INFORMATION (Score: )

cvss4

Base Score: 5.6

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:P/PR:N/UI:A/VC:N/VI:N/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-59856

SUMMARY

Vim is an open source, command line text editor. Prior to 9.2.0736, the PHP omni-completion script in runtime/autoload/phpcomplete.vim interpolates a class or trait name, taken from the contents of the edited buffer, into a search() pattern that is run via win_execute() without escaping. A name containing a single quote can terminate the search() string argument early, and because the bar is honored as an Ex command separator, the remainder of the name is run as Ex commands; via the :! command this allows arbitrary operating-system command execution when a victim opens a crafted PHP file and invokes omni-completion. This issue is fixed in version 9.2.0736.

Published

Date2026-07-09

Updated

Date2026-07-09

RISK INFORMATION (Score: )

cvss4

Base Score: 8.4

Complexity: LOW

CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-59855

SUMMARY

SiYuan is an open-source personal knowledge management system. Prior to 3.7.1, Asset.render in app/src/asset/index.ts interpolates the unsanitized this.path value into HTML assigned to innerHTML, allowing a crafted asset link containing a double quote to break out of the src attribute, inject an event handler, and execute JavaScript that can run OS commands in the Electron renderer. This issue is fixed in versions 3.7.1-alpha.2 and 3.7.1.

Published

Date2026-07-09

Updated

Date2026-07-09

RISK INFORMATION (Score: )

cvss4

Base Score: 8.6

Complexity: LOW

CVSS:4.0/AV:N/AC:L/AT:N/PR:N/UI:A/VC:H/VI:H/VA:H/SC:N/SI:N/SA:N/E:X/CR:X/IR:X/AR:X/MAV:X/MAC:X/MAT:X/MPR:X/MUI:X/MVC:X/MVI:X/MVA:X/MSC:X/MSI:X/MSA:X/S:X/AU:X/R:X/V:X/RE:X/U:X

Impact Score

Exploitability

REFERENCES

CVE-2026-59854

SUMMARY

SiYuan is an open-source personal knowledge management system. Prior to 3.7.1, POST /api/file/globalCopyFiles accepts attacker-supplied absolute source paths and relies on util.IsSensitivePath in kernel/util/path.go, whose denylist misses common home-directory credential files such as .git-credentials, .netrc, .pgpass, .kube/config, .docker/config.json, and .gnupg, allowing an authenticated administrator or API-token user to copy those files into the workspace and exfiltrate them through the file API. This issue is fixed in versions 3.7.1-alpha.2 and 3.7.1.

Published

Date2026-07-09

Updated

Date2026-07-09

RISK INFORMATION (Score: 4.9)

cvss3

Base Score: 4.9

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:H/UI:N/S:U/C:H/I:N/A:N

Impact Score

3.6

Exploitability

1.2

REFERENCES

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…